[144] Revolution Medicines, Inc. SEC Filing

robot
Abstract generation in progress

This article details a Form 144 SEC filing by Revolution Medicines, Inc. (RVMD) concerning a proposed sale of securities. The filing indicates a sale of 37,450 shares of common stock acquired via stock option on April 1, 2025, with an aggregate market value of $3,578,823.12, scheduled for approximately March 25, 2026, on NASDAQ. The document provides detailed information about the filer, issuer, and the securities to be sold.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin